CSPAN2 Book TV July 20, 2013
Submitted to the fda came from hundreds of patients. If you had used ten patients, its like studying twins in a way because its all the same disease. So if they had used ten patients and given a kind of conditional approval, then everyone would have gotten the drug a lot faster possibly. So things like that, you know, could be in the are in the works. But its difficult to get them working. Jessica, youve outlined the fda is coming up with a new designation, a breakthrough designation status which really fast tracks drugs perfectly. It puts the companies in contact with the data and helps them ...
Source: archive.org
